Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Davidoff

Showing results (331-340 of 488) with videos related to

Pageof 49
Sort By:
Plos One|December 15, 2015
Correction: Molecular Heterogeneity in a Patient-Derived Glioblastoma Xenoline is Regulated by Different Cancer Stem Cell PopulationsJo Meagan Garner, David W Ellison, David Finkelstein, et al.
Plos One|May 9, 2015
Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populationsJo Meagan Garner, David W Ellison, David Finkelstein, et al.
Journal of Pediatric Surgery|July 31, 2013
Is adrenalectomy necessary during unilateral nephrectomy for Wilms Tumor? A report from the Children's Oncology GroupKathleen Kieran, James R Anderson, Jeffrey S Dome, et al.
Oncoimmunology|August 17, 2017
An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumorsSatyen Harish Gohil, Solange Rosa Paredes-Moscosso, Micaela Harrasser, et al.
British Journal of Haematology|November 11, 2014
The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphomaDeepa Bhojwani, Mary B McCarville, John K Choi, et al.
Journal of Pediatric Surgery|November 6, 2019
Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapyDavid Yanishevski, M Beth McCarville, Mikhail Doubrovin, et al.
Surgery|January 31, 2012
Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibitionWayne S Orr, Jason W Denbo, Karim R Saab, et al.
Cancer|January 31, 2009
A phase 1/pilot study of radiofrequency ablation for the treatment of recurrent pediatric solid tumorsFredric A Hoffer, Najat C Daw, Xiaoping Xiong, et al.
Journal of Pediatric Surgery|January 23, 2009
Neural progenitor cell-mediated delivery of osteoprotegerin limits disease progression in a preclinical model of neuroblastoma bone metastasisThomas L Sims, J Blair Hamner, Rebecca A Bush, et al.
Pediatric Blood & Cancer|March 19, 2026
Symptomatic Recurrent Splenomegaly Following Partial Splenectomy in Patients With Hereditary SpherocytosisAbdelhafeez H Abdelhafeez, Karson Rosenberger, Peyton Crest, et al.
Pageof 49

Showing results (331-340 of 488) with videos related to

Sort By:
Pageof 49
Plos One|December 15, 2015
Correction: Molecular Heterogeneity in a Patient-Derived Glioblastoma Xenoline is Regulated by Different Cancer Stem Cell PopulationsJo Meagan Garner, David W Ellison, David Finkelstein, et al.
Plos One|May 9, 2015
Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populationsJo Meagan Garner, David W Ellison, David Finkelstein, et al.
Journal of Pediatric Surgery|July 31, 2013
Is adrenalectomy necessary during unilateral nephrectomy for Wilms Tumor? A report from the Children's Oncology GroupKathleen Kieran, James R Anderson, Jeffrey S Dome, et al.
Oncoimmunology|August 17, 2017
An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumorsSatyen Harish Gohil, Solange Rosa Paredes-Moscosso, Micaela Harrasser, et al.
British Journal of Haematology|November 11, 2014
The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphomaDeepa Bhojwani, Mary B McCarville, John K Choi, et al.
Journal of Pediatric Surgery|November 6, 2019
Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapyDavid Yanishevski, M Beth McCarville, Mikhail Doubrovin, et al.
Surgery|January 31, 2012
Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibitionWayne S Orr, Jason W Denbo, Karim R Saab, et al.
Cancer|January 31, 2009
A phase 1/pilot study of radiofrequency ablation for the treatment of recurrent pediatric solid tumorsFredric A Hoffer, Najat C Daw, Xiaoping Xiong, et al.
Journal of Pediatric Surgery|January 23, 2009
Neural progenitor cell-mediated delivery of osteoprotegerin limits disease progression in a preclinical model of neuroblastoma bone metastasisThomas L Sims, J Blair Hamner, Rebecca A Bush, et al.
Pediatric Blood & Cancer|March 19, 2026
Symptomatic Recurrent Splenomegaly Following Partial Splenectomy in Patients With Hereditary SpherocytosisAbdelhafeez H Abdelhafeez, Karson Rosenberger, Peyton Crest, et al.
Pageof 49